The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drugs for Schistosomiasis Market Research Report 2025
Synopsis
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global Drugs for Schistosomiasis market was valued at US$ 82 million in 2023 and is anticipated to reach US$ 106.8 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
This report aims to provide a comprehensive presentation of the global market for Drugs for Schistosomiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Schistosomiasis.
Report Scope
The Drugs for Schistosomiasis market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Schistosomiasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Schistosomiasis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Segment by Type
Praziquantel
Oxamniquine
Other
Segment by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs for Schistosomiasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global Drugs for Schistosomiasis market was valued at US$ 82 million in 2023 and is anticipated to reach US$ 106.8 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
This report aims to provide a comprehensive presentation of the global market for Drugs for Schistosomiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Schistosomiasis.
Report Scope
The Drugs for Schistosomiasis market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Schistosomiasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Schistosomiasis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Segment by Type
Praziquantel
Oxamniquine
Other
Segment by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs for Schistosomiasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Drugs for Schistosomiasis Market Overview
1.1 Product Overview and Scope of Drugs for Schistosomiasis
1.2 Drugs for Schistosomiasis Segment by Type
1.2.1 Global Drugs for Schistosomiasis Market Value Comparison by Type (2024-2030)
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Drugs for Schistosomiasis Segment by Application
1.3.1 Global Drugs for Schistosomiasis Market Value by Application: (2024-2030)
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Global Drugs for Schistosomiasis Market Size Estimates and Forecasts
1.4.1 Global Drugs for Schistosomiasis Revenue 2019-2030
1.4.2 Global Drugs for Schistosomiasis Sales 2019-2030
1.4.3 Global Drugs for Schistosomiasis Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drugs for Schistosomiasis Market Competition by Manufacturers
2.1 Global Drugs for Schistosomiasis Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drugs for Schistosomiasis Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drugs for Schistosomiasis Average Price by Manufacturers (2019-2024)
2.4 Global Drugs for Schistosomiasis Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drugs for Schistosomiasis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs for Schistosomiasis, Product Type & Application
2.7 Drugs for Schistosomiasis Market Competitive Situation and Trends
2.7.1 Drugs for Schistosomiasis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drugs for Schistosomiasis Players Market Share by Revenue
2.7.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drugs for Schistosomiasis Retrospective Market Scenario by Region
3.1 Global Drugs for Schistosomiasis Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drugs for Schistosomiasis Global Drugs for Schistosomiasis Sales by Region: 2019-2030
3.2.1 Global Drugs for Schistosomiasis Sales by Region: 2019-2024
3.2.2 Global Drugs for Schistosomiasis Sales by Region: 2025-2030
3.3 Global Drugs for Schistosomiasis Global Drugs for Schistosomiasis Revenue by Region: 2019-2030
3.3.1 Global Drugs for Schistosomiasis Revenue by Region: 2019-2024
3.3.2 Global Drugs for Schistosomiasis Revenue by Region: 2025-2030
3.4 North America Drugs for Schistosomiasis Market Facts & Figures by Country
3.4.1 North America Drugs for Schistosomiasis Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drugs for Schistosomiasis Sales by Country (2019-2030)
3.4.3 North America Drugs for Schistosomiasis Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drugs for Schistosomiasis Market Facts & Figures by Country
3.5.1 Europe Drugs for Schistosomiasis Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drugs for Schistosomiasis Sales by Country (2019-2030)
3.5.3 Europe Drugs for Schistosomiasis Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs for Schistosomiasis Market Facts & Figures by Country
3.6.1 Asia Pacific Drugs for Schistosomiasis Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drugs for Schistosomiasis Sales by Country (2019-2030)
3.6.3 Asia Pacific Drugs for Schistosomiasis Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drugs for Schistosomiasis Market Facts & Figures by Country
3.7.1 Latin America Drugs for Schistosomiasis Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drugs for Schistosomiasis Sales by Country (2019-2030)
3.7.3 Latin America Drugs for Schistosomiasis Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs for Schistosomiasis Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs for Schistosomiasis Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drugs for Schistosomiasis Sales by Type (2019-2030)
4.1.1 Global Drugs for Schistosomiasis Sales by Type (2019-2024)
4.1.2 Global Drugs for Schistosomiasis Sales by Type (2025-2030)
4.1.3 Global Drugs for Schistosomiasis Sales Market Share by Type (2019-2030)
4.2 Global Drugs for Schistosomiasis Revenue by Type (2019-2030)
4.2.1 Global Drugs for Schistosomiasis Revenue by Type (2019-2024)
4.2.2 Global Drugs for Schistosomiasis Revenue by Type (2025-2030)
4.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Type (2019-2030)
4.3 Global Drugs for Schistosomiasis Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drugs for Schistosomiasis Sales by Application (2019-2030)
5.1.1 Global Drugs for Schistosomiasis Sales by Application (2019-2024)
5.1.2 Global Drugs for Schistosomiasis Sales by Application (2025-2030)
5.1.3 Global Drugs for Schistosomiasis Sales Market Share by Application (2019-2030)
5.2 Global Drugs for Schistosomiasis Revenue by Application (2019-2030)
5.2.1 Global Drugs for Schistosomiasis Revenue by Application (2019-2024)
5.2.2 Global Drugs for Schistosomiasis Revenue by Application (2025-2030)
5.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Application (2019-2030)
5.3 Global Drugs for Schistosomiasis Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shin Poong
6.1.1 Shin Poong Corporation Information
6.1.2 Shin Poong Description and Business Overview
6.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shin Poong Drugs for Schistosomiasis Product Portfolio
6.1.5 Shin Poong Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Drugs for Schistosomiasis Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Drugs for Schistosomiasis Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 EIPICO
6.4.1 EIPICO Corporation Information
6.4.2 EIPICO Description and Business Overview
6.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EIPICO Drugs for Schistosomiasis Product Portfolio
6.4.5 EIPICO Recent Developments/Updates
6.5 Chandra Bhagat Pharma
6.5.1 Chandra Bhagat Pharma Corporation Information
6.5.2 Chandra Bhagat Pharma Description and Business Overview
6.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Portfolio
6.5.5 Chandra Bhagat Pharma Recent Developments/Updates
6.6 Taj Pharmaceuticals
6.6.1 Taj Pharmaceuticals Corporation Information
6.6.2 Taj Pharmaceuticals Description and Business Overview
6.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Product Portfolio
6.6.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs for Schistosomiasis Industry Chain Analysis
7.2 Drugs for Schistosomiasis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs for Schistosomiasis Production Mode & Process
7.4 Drugs for Schistosomiasis Sales and Marketing
7.4.1 Drugs for Schistosomiasis Sales Channels
7.4.2 Drugs for Schistosomiasis Distributors
7.5 Drugs for Schistosomiasis Customers
8 Drugs for Schistosomiasis Market Dynamics
8.1 Drugs for Schistosomiasis Industry Trends
8.2 Drugs for Schistosomiasis Market Drivers
8.3 Drugs for Schistosomiasis Market Challenges
8.4 Drugs for Schistosomiasis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
